Cite
Drummond D, Dana J, Berteloot L, et al. Lumacaftor-ivacaftor effects on cystic fibrosis-related liver involvement in adolescents with homozygous F508 del-CFTR. J Cyst Fibros. 2021;doi: 10.1016/j.jcf.2021.07.018.
Drummond, D., Dana, J., Berteloot, L., Schneider-Futschik, E. K., Chedevergne, F., Bailly-Botuha, C., Nguyen-Khoa, T., Cornet, M., Le Bourgeois, M., Debray, D., Girard, M., & Sermet-Gaudelus, I. (2021). Lumacaftor-ivacaftor effects on cystic fibrosis-related liver involvement in adolescents with homozygous F508 del-CFTR. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, . https://doi.org/10.1016/j.jcf.2021.07.018
Drummond, David, et al. "Lumacaftor-ivacaftor effects on cystic fibrosis-related liver involvement in adolescents with homozygous F508 del-CFTR." Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. (2021). doi: https://doi.org/10.1016/j.jcf.2021.07.018
Drummond D, Dana J, Berteloot L, Schneider-Futschik EK, Chedevergne F, Bailly-Botuha C, Nguyen-Khoa T, Cornet M, Le Bourgeois M, Debray D, Girard M, Sermet-Gaudelus I. Lumacaftor-ivacaftor effects on cystic fibrosis-related liver involvement in adolescents with homozygous F508 del-CFTR. J Cyst Fibros. 2021 Aug 25; doi: 10.1016/j.jcf.2021.07.018. Epub 2021 Aug 25. PMID: 34454846.
Copy
Download .nbib